Drugs / Cyclin B1 Peptide
last change Dec 2015 re-read 3 minutes ago

Cyclin B1 Peptide

Vaccine

Developed for
non-small cell lung carcinoma
Investigated by
Milton S. Hershey Medical Center

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01398124 Dec 2012 → Dec 2014 non-small cell lung carcinoma Milton S. Hershey Medical Center Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cyclin B1 Peptide ClinicalTrials.gov intervention name — accepted as the source's own label NCT01398124 ↗
Modality Vaccine “Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine” NCT01398124 ↗